Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REGENERX-BIOPHARMACEUTICA-120787471/news/RegeneRx-Biopharmaceuticals-Inc-First-Patient-Enrolled-into-U-S-Phase-3-Neurotrophic-Keratitis-43496334/?utm_source=whatsapp&utm_medium=social&utm_campaign=share